Harnessing ExDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach.

Ianniello Z, Lu H, Quijano E, Colón-Ríos DA, Rackear M, Bommireddy V, Ludwig DL, Shen Z, Glazer PM

DOI: 10.1186/s12943-025-02462-z
Published: 2025 Oct 13
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-025-02462-z,
  title = {Harnessing ExDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach.},
  author = {Ianniello Z and Lu H and Quijano E and Colón-Ríos DA and Rackear M and Bommireddy V and Ludwig DL and Shen Z and Glazer PM},
  year = {2025},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-025-02462-z},
  url = {https://doi.org/10.1186/s12943-025-02462-z}
}

RIS

TY  - JOUR
TI  - Harnessing ExDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach.
AU  - Ianniello Z
AU  - Lu H
AU  - Quijano E
AU  - Colón-Ríos DA
AU  - Rackear M
AU  - Bommireddy V
AU  - Ludwig DL
AU  - Shen Z
AU  - Glazer PM
PY  - 2025
JO  - Molecular cancer
DO  - 10.1186/s12943-025-02462-z
UR  - https://doi.org/10.1186/s12943-025-02462-z
ER  -

APA

Z, I., H, L., E, Q., DA, C., M, R., V, B., DL, L., Z, S., & PM, G. (2025). Harnessing ExDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach.. Molecular cancer. https://doi.org/10.1186/s12943-025-02462-z

Source records

pubmed · retrieved 2026-09-26T21:52:17.634Z